Manuel Alba sold $5.5M of ALAB
director at Astera Labs, Inc.. 33,000 shares at an average of $166.18, traded Dec 1, 2025, filed Dec 3, 2025.
Score components
- +15RoleDirector
- +25Trade size$5.5M at market
- 0Share of holdings soldSold 8.6% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001134727-25-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -991 | $153.80 | $152k | 384,872 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -711 | $154.74 | $110k | 384,161 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -234 | $155.50 | $36k | 383,927 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -178 | $156.88 | $28k | 383,749 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -93 | $158.11 | $15k | 383,656 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -212 | $159.29 | $34k | 383,444 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -235 | $160.54 | $38k | 383,209 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -897 | $161.63 | $145k | 382,312 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -510 | $162.52 | $83k | 381,802 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,362 | $163.68 | $387k | 379,440 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,742 | $164.60 | $451k | 376,698 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -8,502 | $165.39 | $1.4M | 368,196 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,831 | $166.67 | $472k | 365,365 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,455 | $167.52 | $411k | 362,910 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,008 | $168.57 | $170k | 361,902 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,952 | $169.84 | $332k | 359,950 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -3,019 | $170.63 | $515k | 356,931 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,680 | $171.57 | $460k | 354,251 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,388 | $172.57 | $240k | 352,863 | Dec 3, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $25M 150,000 shares | -9% | |
| 25Weak | Astera Labs, Inc. | Jack R Lazar director | $374k 2,500 shares | -3% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $1.7M 11,430 shares | -6% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $13M 90,459 shares | -4% | |
| 50Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $668k 4,620 shares | -3% | |
| 60Notable | Astera Labs, Inc. | Sanjay Gajendra President and COO | $13M 90,459 shares | -5% | |
| 20Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.9M 10,000 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.